STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at ... Business Wire (press release) PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced that the 4-month ... |
